Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid (2016)
- Autores:
- Autores USP: GATTAZ, WAGNER FARID - FM ; FORLENZA, ORESTES VICENTE - FM
- Unidade: FM
- DOI: 10.1111/bdi.12360
- Assuntos: BIOMARCADORES; TRANSTORNO BIPOLAR; LÍQUIDO CEFALORRAQUIDIANO; DOENÇA DE ALZHEIMER
- Idioma: Inglês
- Imprenta:
- Local: Copenhagen
- Data de publicação: 2016
- Fonte:
- Título do periódico: Bipolar Disorders
- ISSN: 1398-5647
- Volume/Número/Paginação/Ano: v. 18, n. 1, p. 63-70, 2016
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
FORLENZA, Orestes V. et al. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid. Bipolar Disorders, v. 18, n. 1, p. 63-70, 2016Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1111/bdi.12360/epdf. Acesso em: 19 abr. 2024. -
APA
Forlenza, O. V., Aprahamian, I., Radanovic, M., Talib, L. L., Camargo, M. Z. A., Stella, F., et al. (2016). Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid. Bipolar Disorders, 18( 1), 63-70. doi:10.1111/bdi.12360 -
NLM
Forlenza OV, Aprahamian I, Radanovic M, Talib LL, Camargo MZA, Stella F, Machado-Vieira R, Gattaz WF. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid [Internet]. Bipolar Disorders. 2016 ; 18( 1): 63-70.[citado 2024 abr. 19 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/bdi.12360/epdf -
Vancouver
Forlenza OV, Aprahamian I, Radanovic M, Talib LL, Camargo MZA, Stella F, Machado-Vieira R, Gattaz WF. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid [Internet]. Bipolar Disorders. 2016 ; 18( 1): 63-70.[citado 2024 abr. 19 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/bdi.12360/epdf - Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study
- A radioenzymatic assay to identify three groups of phospholipase A2 in platelets
- Interleukin-1β Serum Levels is Increased in Antidepressant-Free Elderly Depressed Patients
- Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept study
- Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study
- Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients
- Long-Term Lithium Treatment Increases cPLA2 and iPLA2 Activity in Cultured Cortical and Hippocampal Neurons
- Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study
- Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression
- Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein
Informações sobre o DOI: 10.1111/bdi.12360 (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
